Global Cell-based Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 112

Published Date: 05 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Cell-based Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Cell-based Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell-based Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell-based Flu Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell-based Flu Vaccine total production and demand, 2018-2029, (M Doses)
Global Cell-based Flu Vaccine total production value, 2018-2029, (USD Million)
Global Cell-based Flu Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Cell-based Flu Vaccine consumption by region & country, CAGR, 2018-2029 & (M Doses)
U.S. VS China: Cell-based Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Cell-based Flu Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Doses)
Global Cell-based Flu Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Cell-based Flu Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
This reports profiles key players in the global Cell-based Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi, Pfizer, MedImmune, LLC, Intravacc, CSL Limited, E. Merck KG, Novartis and Danaher Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell-based Flu Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell-based Flu Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell-based Flu Vaccine Market, Segmentation by Type
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Global Cell-based Flu Vaccine Market, Segmentation by Application
    Aldults
    Children

Companies Profiled:
    GlaxoSmithKline
    Sanofi
    Pfizer
    MedImmune, LLC
    Intravacc
    CSL Limited
    E. Merck KG
    Novartis
    Danaher Corporation
    SINOVAC

Key Questions Answered
1. How big is the global Cell-based Flu Vaccine market?
2. What is the demand of the global Cell-based Flu Vaccine market?
3. What is the year over year growth of the global Cell-based Flu Vaccine market?
4. What is the production and production value of the global Cell-based Flu Vaccine market?
5. Who are the key producers in the global Cell-based Flu Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell-based Flu Vaccine Introduction
    1.2 World Cell-based Flu Vaccine Supply & Forecast
        1.2.1 World Cell-based Flu Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Cell-based Flu Vaccine Production (2018-2029)
        1.2.3 World Cell-based Flu Vaccine Pricing Trends (2018-2029)
    1.3 World Cell-based Flu Vaccine Production by Region (Based on Production Site)
        1.3.1 World Cell-based Flu Vaccine Production Value by Region (2018-2029)
        1.3.2 World Cell-based Flu Vaccine Production by Region (2018-2029)
        1.3.3 World Cell-based Flu Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Cell-based Flu Vaccine Production (2018-2029)
        1.3.5 Europe Cell-based Flu Vaccine Production (2018-2029)
        1.3.6 China Cell-based Flu Vaccine Production (2018-2029)
        1.3.7 Japan Cell-based Flu Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell-based Flu Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell-based Flu Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cell-based Flu Vaccine Demand (2018-2029)
    2.2 World Cell-based Flu Vaccine Consumption by Region
        2.2.1 World Cell-based Flu Vaccine Consumption by Region (2018-2023)
        2.2.2 World Cell-based Flu Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Cell-based Flu Vaccine Consumption (2018-2029)
    2.4 China Cell-based Flu Vaccine Consumption (2018-2029)
    2.5 Europe Cell-based Flu Vaccine Consumption (2018-2029)
    2.6 Japan Cell-based Flu Vaccine Consumption (2018-2029)
    2.7 South Korea Cell-based Flu Vaccine Consumption (2018-2029)
    2.8 ASEAN Cell-based Flu Vaccine Consumption (2018-2029)
    2.9 India Cell-based Flu Vaccine Consumption (2018-2029)

3 World Cell-based Flu Vaccine Manufacturers Competitive Analysis
    3.1 World Cell-based Flu Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Cell-based Flu Vaccine Production by Manufacturer (2018-2023)
    3.3 World Cell-based Flu Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Cell-based Flu Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Cell-based Flu Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Cell-based Flu Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Cell-based Flu Vaccine in 2022
    3.6 Cell-based Flu Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Cell-based Flu Vaccine Market: Region Footprint
        3.6.2 Cell-based Flu Vaccine Market: Company Product Type Footprint
        3.6.3 Cell-based Flu Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Cell-based Flu Vaccine Production Value Comparison
        4.1.1 United States VS China: Cell-based Flu Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Cell-based Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Cell-based Flu Vaccine Production Comparison
        4.2.1 United States VS China: Cell-based Flu Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cell-based Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Cell-based Flu Vaccine Consumption Comparison
        4.3.1 United States VS China: Cell-based Flu Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Cell-based Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Cell-based Flu Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Cell-based Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Cell-based Flu Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Cell-based Flu Vaccine Production (2018-2023)
    4.5 China Based Cell-based Flu Vaccine Manufacturers and Market Share
        4.5.1 China Based Cell-based Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Cell-based Flu Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Cell-based Flu Vaccine Production (2018-2023)
    4.6 Rest of World Based Cell-based Flu Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Cell-based Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Cell-based Flu Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Cell-based Flu Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Cell-based Flu Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Trivalent Influenza Vaccine
        5.2.2 Quadrivalent Influenza Vaccine
    5.3 Market Segment by Type
        5.3.1 World Cell-based Flu Vaccine Production by Type (2018-2029)
        5.3.2 World Cell-based Flu Vaccine Production Value by Type (2018-2029)
        5.3.3 World Cell-based Flu Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cell-based Flu Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Aldults
        6.2.2 Children
    6.3 Market Segment by Application
        6.3.1 World Cell-based Flu Vaccine Production by Application (2018-2029)
        6.3.2 World Cell-based Flu Vaccine Production Value by Application (2018-2029)
        6.3.3 World Cell-based Flu Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Details
        7.1.2 GlaxoSmithKline Major Business
        7.1.3 GlaxoSmithKline Cell-based Flu Vaccine Product and Services
        7.1.4 GlaxoSmithKline Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 GlaxoSmithKline Recent Developments/Updates
        7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Cell-based Flu Vaccine Product and Services
        7.2.4 Sanofi Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer Cell-based Flu Vaccine Product and Services
        7.3.4 Pfizer Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 MedImmune, LLC
        7.4.1 MedImmune, LLC Details
        7.4.2 MedImmune, LLC Major Business
        7.4.3 MedImmune, LLC Cell-based Flu Vaccine Product and Services
        7.4.4 MedImmune, LLC Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 MedImmune, LLC Recent Developments/Updates
        7.4.6 MedImmune, LLC Competitive Strengths & Weaknesses
    7.5 Intravacc
        7.5.1 Intravacc Details
        7.5.2 Intravacc Major Business
        7.5.3 Intravacc Cell-based Flu Vaccine Product and Services
        7.5.4 Intravacc Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Intravacc Recent Developments/Updates
        7.5.6 Intravacc Competitive Strengths & Weaknesses
    7.6 CSL Limited
        7.6.1 CSL Limited Details
        7.6.2 CSL Limited Major Business
        7.6.3 CSL Limited Cell-based Flu Vaccine Product and Services
        7.6.4 CSL Limited Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 CSL Limited Recent Developments/Updates
        7.6.6 CSL Limited Competitive Strengths & Weaknesses
    7.7 E. Merck KG
        7.7.1 E. Merck KG Details
        7.7.2 E. Merck KG Major Business
        7.7.3 E. Merck KG Cell-based Flu Vaccine Product and Services
        7.7.4 E. Merck KG Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 E. Merck KG Recent Developments/Updates
        7.7.6 E. Merck KG Competitive Strengths & Weaknesses
    7.8 Novartis
        7.8.1 Novartis Details
        7.8.2 Novartis Major Business
        7.8.3 Novartis Cell-based Flu Vaccine Product and Services
        7.8.4 Novartis Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Novartis Recent Developments/Updates
        7.8.6 Novartis Competitive Strengths & Weaknesses
    7.9 Danaher Corporation
        7.9.1 Danaher Corporation Details
        7.9.2 Danaher Corporation Major Business
        7.9.3 Danaher Corporation Cell-based Flu Vaccine Product and Services
        7.9.4 Danaher Corporation Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Danaher Corporation Recent Developments/Updates
        7.9.6 Danaher Corporation Competitive Strengths & Weaknesses
    7.10 SINOVAC
        7.10.1 SINOVAC Details
        7.10.2 SINOVAC Major Business
        7.10.3 SINOVAC Cell-based Flu Vaccine Product and Services
        7.10.4 SINOVAC Cell-based Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 SINOVAC Recent Developments/Updates
        7.10.6 SINOVAC Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell-based Flu Vaccine Industry Chain
    8.2 Cell-based Flu Vaccine Upstream Analysis
        8.2.1 Cell-based Flu Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Cell-based Flu Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Cell-based Flu Vaccine Production Mode
    8.6 Cell-based Flu Vaccine Procurement Model
    8.7 Cell-based Flu Vaccine Industry Sales Model and Sales Channels
        8.7.1 Cell-based Flu Vaccine Sales Model
        8.7.2 Cell-based Flu Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell-based Flu Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Cell-based Flu Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Cell-based Flu Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Cell-based Flu Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Cell-based Flu Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Cell-based Flu Vaccine Production by Region (2018-2023) & (M Doses)
    Table 7. World Cell-based Flu Vaccine Production by Region (2024-2029) & (M Doses)
    Table 8. World Cell-based Flu Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Cell-based Flu Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Cell-based Flu Vaccine Average Price by Region (2018-2023) & (US$/Dose)
    Table 11. World Cell-based Flu Vaccine Average Price by Region (2024-2029) & (US$/Dose)
    Table 12. Cell-based Flu Vaccine Major Market Trends
    Table 13. World Cell-based Flu Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Doses)
    Table 14. World Cell-based Flu Vaccine Consumption by Region (2018-2023) & (M Doses)
    Table 15. World Cell-based Flu Vaccine Consumption Forecast by Region (2024-2029) & (M Doses)
    Table 16. World Cell-based Flu Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Cell-based Flu Vaccine Producers in 2022
    Table 18. World Cell-based Flu Vaccine Production by Manufacturer (2018-2023) & (M Doses)
    Table 19. Production Market Share of Key Cell-based Flu Vaccine Producers in 2022
    Table 20. World Cell-based Flu Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 21. Global Cell-based Flu Vaccine Company Evaluation Quadrant
    Table 22. World Cell-based Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Cell-based Flu Vaccine Production Site of Key Manufacturer
    Table 24. Cell-based Flu Vaccine Market: Company Product Type Footprint
    Table 25. Cell-based Flu Vaccine Market: Company Product Application Footprint
    Table 26. Cell-based Flu Vaccine Competitive Factors
    Table 27. Cell-based Flu Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Cell-based Flu Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Cell-based Flu Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Cell-based Flu Vaccine Production Comparison, (2018 & 2022 & 2029) & (M Doses)
    Table 31. United States VS China Cell-based Flu Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (M Doses)
    Table 32. United States Based Cell-based Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Cell-based Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Cell-based Flu Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Cell-based Flu Vaccine Production (2018-2023) & (M Doses)
    Table 36. United States Based Manufacturers Cell-based Flu Vaccine Production Market Share (2018-2023)
    Table 37. China Based Cell-based Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Cell-based Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Cell-based Flu Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Cell-based Flu Vaccine Production (2018-2023) & (M Doses)
    Table 41. China Based Manufacturers Cell-based Flu Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Cell-based Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Cell-based Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Cell-based Flu Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Cell-based Flu Vaccine Production (2018-2023) & (M Doses)
    Table 46. Rest of World Based Manufacturers Cell-based Flu Vaccine Production Market Share (2018-2023)
    Table 47. World Cell-based Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Cell-based Flu Vaccine Production by Type (2018-2023) & (M Doses)
    Table 49. World Cell-based Flu Vaccine Production by Type (2024-2029) & (M Doses)
    Table 50. World Cell-based Flu Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Cell-based Flu Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Cell-based Flu Vaccine Average Price by Type (2018-2023) & (US$/Dose)
    Table 53. World Cell-based Flu Vaccine Average Price by Type (2024-2029) & (US$/Dose)
    Table 54. World Cell-based Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Cell-based Flu Vaccine Production by Application (2018-2023) & (M Doses)
    Table 56. World Cell-based Flu Vaccine Production by Application (2024-2029) & (M Doses)
    Table 57. World Cell-based Flu Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Cell-based Flu Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Cell-based Flu Vaccine Average Price by Application (2018-2023) & (US$/Dose)
    Table 60. World Cell-based Flu Vaccine Average Price by Application (2024-2029) & (US$/Dose)
    Table 61. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 62. GlaxoSmithKline Major Business
    Table 63. GlaxoSmithKline Cell-based Flu Vaccine Product and Services
    Table 64. GlaxoSmithKline Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. GlaxoSmithKline Recent Developments/Updates
    Table 66. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 68. Sanofi Major Business
    Table 69. Sanofi Cell-based Flu Vaccine Product and Services
    Table 70. Sanofi Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Sanofi Recent Developments/Updates
    Table 72. Sanofi Competitive Strengths & Weaknesses
    Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 74. Pfizer Major Business
    Table 75. Pfizer Cell-based Flu Vaccine Product and Services
    Table 76. Pfizer Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Pfizer Recent Developments/Updates
    Table 78. Pfizer Competitive Strengths & Weaknesses
    Table 79. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
    Table 80. MedImmune, LLC Major Business
    Table 81. MedImmune, LLC Cell-based Flu Vaccine Product and Services
    Table 82. MedImmune, LLC Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. MedImmune, LLC Recent Developments/Updates
    Table 84. MedImmune, LLC Competitive Strengths & Weaknesses
    Table 85. Intravacc Basic Information, Manufacturing Base and Competitors
    Table 86. Intravacc Major Business
    Table 87. Intravacc Cell-based Flu Vaccine Product and Services
    Table 88. Intravacc Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Intravacc Recent Developments/Updates
    Table 90. Intravacc Competitive Strengths & Weaknesses
    Table 91. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 92. CSL Limited Major Business
    Table 93. CSL Limited Cell-based Flu Vaccine Product and Services
    Table 94. CSL Limited Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. CSL Limited Recent Developments/Updates
    Table 96. CSL Limited Competitive Strengths & Weaknesses
    Table 97. E. Merck KG Basic Information, Manufacturing Base and Competitors
    Table 98. E. Merck KG Major Business
    Table 99. E. Merck KG Cell-based Flu Vaccine Product and Services
    Table 100. E. Merck KG Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. E. Merck KG Recent Developments/Updates
    Table 102. E. Merck KG Competitive Strengths & Weaknesses
    Table 103. Novartis Basic Information, Manufacturing Base and Competitors
    Table 104. Novartis Major Business
    Table 105. Novartis Cell-based Flu Vaccine Product and Services
    Table 106. Novartis Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Novartis Recent Developments/Updates
    Table 108. Novartis Competitive Strengths & Weaknesses
    Table 109. Danaher Corporation Basic Information, Manufacturing Base and Competitors
    Table 110. Danaher Corporation Major Business
    Table 111. Danaher Corporation Cell-based Flu Vaccine Product and Services
    Table 112. Danaher Corporation Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Danaher Corporation Recent Developments/Updates
    Table 114. SINOVAC Basic Information, Manufacturing Base and Competitors
    Table 115. SINOVAC Major Business
    Table 116. SINOVAC Cell-based Flu Vaccine Product and Services
    Table 117. SINOVAC Cell-based Flu Vaccine Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Cell-based Flu Vaccine Upstream (Raw Materials)
    Table 119. Cell-based Flu Vaccine Typical Customers
    Table 120. Cell-based Flu Vaccine Typical Distributors
List of Figure
    Figure 1. Cell-based Flu Vaccine Picture
    Figure 2. World Cell-based Flu Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cell-based Flu Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Cell-based Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 5. World Cell-based Flu Vaccine Average Price (2018-2029) & (US$/Dose)
    Figure 6. World Cell-based Flu Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Cell-based Flu Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Cell-based Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 9. Europe Cell-based Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 10. China Cell-based Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 11. Japan Cell-based Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 12. Cell-based Flu Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 15. World Cell-based Flu Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 17. China Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 18. Europe Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 19. Japan Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 20. South Korea Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 21. ASEAN Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 22. India Cell-based Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 23. Producer Shipments of Cell-based Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Cell-based Flu Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Cell-based Flu Vaccine Markets in 2022
    Figure 26. United States VS China: Cell-based Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Cell-based Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cell-based Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Cell-based Flu Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Cell-based Flu Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Cell-based Flu Vaccine Production Market Share 2022
    Figure 32. World Cell-based Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Cell-based Flu Vaccine Production Value Market Share by Type in 2022
    Figure 34. Trivalent Influenza Vaccine
    Figure 35. Quadrivalent Influenza Vaccine
    Figure 36. World Cell-based Flu Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Cell-based Flu Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Cell-based Flu Vaccine Average Price by Type (2018-2029) & (US$/Dose)
    Figure 39. World Cell-based Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Cell-based Flu Vaccine Production Value Market Share by Application in 2022
    Figure 41. Aldults
    Figure 42. Children
    Figure 43. World Cell-based Flu Vaccine Production Market Share by Application (2018-2029)
    Figure 44. World Cell-based Flu Vaccine Production Value Market Share by Application (2018-2029)
    Figure 45. World Cell-based Flu Vaccine Average Price by Application (2018-2029) & (US$/Dose)
    Figure 46. Cell-based Flu Vaccine Industry Chain
    Figure 47. Cell-based Flu Vaccine Procurement Model
    Figure 48. Cell-based Flu Vaccine Sales Model
    Figure 49. Cell-based Flu Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Cell-based Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Cell-based Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cell-based Flu Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Cell-based Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Cell-based Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 23 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cell-based Flu Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Cell-based Flu Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>